Li Yi, Wang Meng, Gao Yanxia, Yang Wen, Xu Qun, Eddleston Michael, Li Li, Yu Xuezhong
Emergency Department, Peking Union Medical College Hospital, Beijing 100730, China.
Department of Science and Technology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Sci Rep. 2015 Nov 25;5:17299. doi: 10.1038/srep17299.
Ingestion of paraquat causes multi-organ failure. Prognosis is best estimated through measurement of blood paraquat concentrations but this facility is not available in most hospitals. We studied the prognostic significance of abnormal pancreatic enzymes for survival. Patients with acute paraquat poisoning were recruited. An extensive series of blood tests including serum amylase were serially checked. Patients were sorted according to their serum amylase activity (normal [<220 U/L], mildly elevated [220 to 660 U/L], elevated [>660 U/L]), and survival compared between groups. 177 patients were enrolled to the study, of whom 67 died and 110 survived. 122 (70.62%), 27 (15.25%) and 25 (14.13%) patients were in the normal, mildly elevated and elevated amylase activity groups, respectively. The case fatality in the elevated group was 100% compared to 17% in the normal group (P < 0.001). We found four independent factors for paraquat death prediction: amylase, PaCO2, leukocyte number, and neutrophil percentage. Models using pancreatic enzyme activity showed good prediction power. We have found that abnormal pancreatic enzymes are useful prognostic marker of death after acute paraquat poisoning. Including serum amylase activity into a prognostic model provides a good prognostication.
摄入百草枯会导致多器官功能衰竭。通过测量血液中百草枯浓度可对预后进行最佳评估,但大多数医院没有这种检测设备。我们研究了胰腺酶异常对急性百草枯中毒患者生存的预后意义。招募了急性百草枯中毒患者。连续进行了一系列广泛的血液检查,包括血清淀粉酶检测。根据患者血清淀粉酶活性(正常[<220 U/L]、轻度升高[220至660 U/L]、升高[>660 U/L])进行分组,并比较各组的生存率。177例患者纳入本研究,其中67例死亡,110例存活。血清淀粉酶活性正常、轻度升高和升高组的患者分别为122例(70.62%)、27例(15.25%)和25例(14.13%)。淀粉酶升高组的病死率为100%,而正常组为17%(P<0.001)。我们发现了四个预测百草枯中毒死亡的独立因素:淀粉酶、动脉血二氧化碳分压(PaCO2)、白细胞计数和中性粒细胞百分比。使用胰腺酶活性的模型显示出良好的预测能力。我们发现胰腺酶异常是急性百草枯中毒后死亡的有用预后标志物。将血清淀粉酶活性纳入预后模型可提供良好的预后评估。